Events & Presentations
Board of Directors
Historic Stock Lookup
Galectin Therapeutics to Webcast Corporate Presentation at the MicroCap Conference on October 25 in Philadelphia
October 17, 2016 | Press Release
Galectin Therapeutics to Present Clinical Data on Selective Non-Invasive Tests for the Development of Novel Therapies for Nonalcoholic Steatohepatitis
October 7, 2016 | Press Release
Galectin Therapeutics’ NASH bid dented, but not derailed, on phase II fibrosis miss (Subscription Required)
September 29, 2016 | News Article
What are galectins and why are they a good target for the treatment of NASH?
Are you conducting clinical trials with GR-MD-02? What results have you seen so far?
Why did you choose to become the CEO of Galectin Therapeutics?
Why is fatty liver disease called "the hidden epidemic?"
What is fibrosis and what role does it play in chronic diseases such as NASH?
Galectin Therapeutics, Inc.
Financial Tear Sheet
Filings & Reports
Stock price updates every 30 minutes.
2015 Year In Review
Latest Corporate Presentation
Media Fact Sheet
Corporate Fact Sheet
Sign up for our latest updates
© 2016 Galectin Therapeutics Inc. - All Rights Reserved
Disclaimer: This site may contain